BOSTON PHARMACEUTICALS

🇰🇪Kenya

Country: 🇰🇪Kenya

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of BOS161721 in Healthy Subjects

Phase 1

Completed

Conditions: Healthy Participants

Interventions: Drug: BOS161721
Drug: Placebo

First Posted Date: 2017-01-30

Last Posted Date: 2020-11-18

Lead Sponsor: Boston Pharmaceuticals

Target Recruit Count: 61

Registration Number: NCT03036865

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy